Peter Jens Lindholm Kurtzhals
Director/Board Member bij Steno Diabetes Center A/S
Oorsprong van het eerstegraads netwerk van Peter Jens Lindholm Kurtzhals
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
117
| Public Company | Pharmaceuticals: Major | 117 |
Steno Diabetes Center A/S
5
| Private Company | 5 | |
Medicon Valley Alliance FMBA
 Medicon Valley Alliance FMBA Miscellaneous Commercial ServicesCommercial Services Medicon Valley Alliance FMBA operates a life science cluster that spans across Denmark and Sweden. The non-profit company is based in the Medicon Valley region.
4
| Non-Profit Organization | Miscellaneous Commercial Services | 4 |
Danmarks Farmaceutiske Universitet
1
| College/University | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Peter Jens Lindholm Kurtzhals via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Maxygen, Inc.
 Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer Corporate Officer/Principal Director/Board Member | |
| SANOFI | Pharmaceuticals: Major | President Director/Board Member Corporate Officer/Principal | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman | |
Novo Nordisk Pharma GmbH
 Novo Nordisk Pharma GmbH Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharma GmbH manufacturers and distributes pharmaceutical products. It offers pharmaceutical products for diabetes, menopause, growth hormones and blood clotting which treats chronic diseases: hemophilia, growth disorders and obesity. The company was founded in 1991 and is headquartered in Mainz, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
| DANSKE BANK A/S | Major Banks | Director/Board Member Director/Board Member President | |
| COLOPLAST A/S | Medical Specialties | Chief Executive Officer Director/Board Member Corporate Officer/Principal | |
| CARLSBERG A/S | Beverages: Alcoholic | Corporate Officer/Principal Director/Board Member Director/Board Member | |
Novo Nordisk Fonden
 Novo Nordisk Fonden Investment Trusts/Mutual FundsMiscellaneous Novo Nordisk Fonden provides basis for the commercial and research activities conducted by the companies. It also supports scientific and humanitarian purposes activities. It awards grants for research within biomedicine, biotechnology, general practice and family medicine, nursing, and art history at public research institutions. It bridges gap between the discoveries made by researchers in biomedicine and biotechnology and their commercial application. The company was founded by August Krogh, Marie Krogh, Harald Pedersen, Hans Christian Hagedorn, August Kongsted and Thorvald Pedersen in 1922 and is headquartered in Hellerup, Denmark. | Investment Trusts/Mutual Funds | Director/Board Member Chairman Chairman Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer | |
Novo Holdings AS (Denmark)
 Novo Holdings AS (Denmark) MiscellaneousMiscellaneous Novo Holding A/S provides financial investments and manages the Novo Nordisk Foundation?s assets. It offers seed and venture capital to development stage companies and takes ownership positions in companies within life science and biotechnology. The company was founded on September 8, 1999 and is headquartered in Hellerup, Denmark. | Miscellaneous | President Chairman Chief Executive Officer Public Communications Contact Director of Finance/CFO Corporate Officer/Principal Director/Board Member Director/Board Member Chief Executive Officer Corporate Officer/Principal Chief Executive Officer Chief Executive Officer | |
| BAVARIAN NORDIC A/S | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Carlsberg Breweries A/S
 Carlsberg Breweries A/S Beverages: AlcoholicConsumer Non-Durables Carlsberg Breweries A/S engages in the production and marketing of beer and soft drinks. The firm's brands include Afsana, Backyard Brew, CELIA, Dahls, and Eriksberg. It operates through the following geographical segments: Western Europe; Asia; Eastern Europe; and Central and Eastern Europe. The company was founded by Jacob Christian Jacobsen in 1847 and is headquartered in Copenhagen, Denmark. | Beverages: Alcoholic | Chairman Director/Board Member | |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Pharmaceuticals: Major | Chairman Chief Executive Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| ALK-ABELLÓ A/S | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member Director/Board Member Director/Board Member | |
DADES A/S
 DADES A/S Real Estate DevelopmentFinance DADES A/S provides real estate investment services. It owns and operates shopping centers, office buildings, and residential properties. The company was founded by Ejnar Danielsen in 1937 and is headquartered in Kongens Lyngby, Denmark. | Real Estate Development | Director/Board Member Director/Board Member Chairman | |
| The University of Edinburgh | College/University | Masters Business Admin Doctorate Degree | |
| Copenhagen Business School | College/University | Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree Masters Business Admin Graduate Degree Graduate Degree Graduate Degree Graduate Degree | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Director/Board Member Chief Executive Officer | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Sales & Marketing Chairman Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Director/Board Member | |
| University of Aarhus | College/University | Graduate Degree Undergraduate Degree Director/Board Member Graduate Degree Graduate Degree Graduate Degree | |
| INNATE PHARMA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Technical University of Denmark | College/University | Chairman Graduate Degree Graduate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Graduate Degree Undergraduate Degree | |
| University of Lund | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| University of Copenhagen | College/University | Graduate Degree Graduate Degree Chairman Doctorate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Graduate Degree Doctorate Degree | |
| University of Southern Denmark | College/University | Undergraduate Degree Graduate Degree Graduate Degree | |
| Scandinavian International Management Institute | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Director of Finance/CFO President President Director of Finance/CFO President Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chairman Chief Executive Officer Chief Operating Officer | |
LEO Fondet
 LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Biotechnology | Chief Executive Officer Director/Board Member Director/Board Member | |
| ASCENDIS PHARMA A/S | Pharmaceuticals: Major | Founder Corporate Officer/Principal Corporate Officer/Principal | |
| Novo Nordisk North America, Inc. | Director of Finance/CFO President Corporate Officer/Principal | ||
Novo Ventures 1 A/S
 Novo Ventures 1 A/S Investment ManagersFinance Novo Ventures (Novo Ventures) is a venture capital operating division of Novo Nordisk Fonden. It engages in investment activities. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Private Equity Investor Corporate Officer/Principal Chief Executive Officer | |
| FORWARD PHARMA A/S | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Novo Nordisk SAS
 Novo Nordisk SAS Pharmaceuticals: MajorHealth Technology Novo Nordisk SAS manufactures pharmaceutical drugs. It produces and sells medicines for the treatment of diabetes, haemophilia, and hormonal disease. The company was founded in 1959 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Corporate Officer/Principal | |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Drugstore Chains | Director/Board Member Chairman Director/Board Member | |
| NNIT A/S | Information Technology Services | Director/Board Member Chairman Director/Board Member Director/Board Member Corporate Officer/Principal Director/Board Member | |
Novo Nordisk Ltd.
 Novo Nordisk Ltd. Medical/Nursing ServicesHealth Services Novo Nordisk Ltd. engages in the sale and marketing of pharmaceutical products for the treatment of chronic conditions in the United Kingdom. It offers medicines for the treatment of diabetes, and hemophilia and bleeding disorders, as well as for growth hormone therapy and hormone replacement therapy. The company is headquartered in Crawley, the United Kingdom. | Medical/Nursing Services | Director/Board Member Director/Board Member Director/Board Member Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Chief Executive Officer Chief Operating Officer Director/Board Member | |
Novo Principal Investments
 Novo Principal Investments Investment ManagersFinance Novo Principal Investments (Novo Principal) is a private equity operating division of Novo Nordisk Fonden. The firm was established in 1999, and is headquartered in Hellerup, Denmark. | Investment Managers | Director of Finance/CFO Chief Executive Officer Chief Executive Officer | |
| CURASIGHT A/S | Medical Specialties | Director/Board Member Chairman Chief Operating Officer | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Financial Conglomerates | Chairman Director of Finance/CFO Chairman Director/Board Member Corporate Officer/Principal Chief Executive Officer | |
LEO Holding A/S (Denmark)
 LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Financial Conglomerates | Chief Executive Officer Director/Board Member Director/Board Member |
Statistieken
Internationaal
| Denemarken | 34 |
| Verenigde Staten | 8 |
| Verenigd Koninkrijk | 4 |
| Frankrijk | 4 |
| Zweden | 3 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 9 |
| Finance | 7 |
| Commercial Services | 3 |
| Consumer Non-Durables | 3 |
Operationeel
| Director/Board Member | 562 |
| Corporate Officer/Principal | 229 |
| Chairman | 203 |
| Independent Dir/Board Member | 146 |
| Chief Executive Officer | 111 |
Sterkste connecties
| Insiders | |
|---|---|
| Eivind Kolding | 50 |
| Göran Albert Ando | 44 |
| Jack Nielsen | 38 |
| Sten Scheibye | 31 |
| Harry H. Penner | 31 |
| Martin MacKay | 28 |
| Claus Tycho Bræstrup | 27 |
| Thomas Paul Koestler | 26 |
| Jeppe Fonager Christiansen | 26 |
| Bruce Carter | 25 |
| Jesper Brandgaard | 25 |
| Sylvie Grégoire | 25 |
| Steen Riisgaard | 24 |
| Helge Lund | 24 |
| Lise Kingo | 23 |
- Beurs
- Insiders
- Peter Jens Lindholm Kurtzhals
- Bedrijfsconnecties
